Australia's largest stock trading and investment forum Australia's #1 stock forum

BOT

Click for more information

0.70%

35.3¢ botanix pharmaceuticals ltd

Nothing has changed!, page-19

First 19 Last

Share
Profile

Follow
LetoMax

1,807 Posts.

133

26/09/23

12:14

Post #: 70029266
Share

Originally posted by sameddie: ↑

With what we now know, being that there were no issues reported on the clinical side, ahead of the final sign off on June 24, the share price, all things being equal, should be above 18c. If you liked it at 18c with all components of approval being unknown, you should really like it now. The most costly and the highest risk component appears done.

Acknowledging of course that there is now a delay and some folks will price that in. Today that looks like 4c. The greatest approval risk and cost, being clinical, is done. That is information we didn’t have last week. We now do. Again, all else being equal, it’s logical that the stock trades higher into the next approval cycle.

There may have been a management oversight here, maybe they were a bit too relaxed and optimised, but it’s hard to pinpoint. If this is the case, it’s incredibly frustrating.

But once bitten twice shy, and I doubt Howie stake his career on what by his own admission, is not a complex task to complete. He will nail this.

I believe they will work harder than ever to make this right, will get it right, and it will be approved.

rock on.

Expand

Yeah. so now the approval that was meant to be today will be in June 2024?????????????????????

BOT Price at posting: 14.0¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

I88

Infini rolls on with soil sampling at Portland Creek not long after making possible 'uranium history'

EMR

Emerald expands underground resource by 105Koz at Cambodian gold mine Okvau

HYT

Twiggy Forrest to acquire 40% of native hydrogen explorer – not long after putting Fortescue Future Industries to sleep

EBR

EBR reaches review milestone for wireless cardiac pacing device

TLG

Talga expands Prospectus Offer to $9M, banks $18.5M overall since end of financial year

There are more pages in this discussion • 74 more messages in this thread...

First 19 Last

Add BOT (ASX) to my watchlist

(20min delay)
Last 35.3¢		Change -0.003(0.70%)		Mkt cap ! $633.5M

Open	High	Low	Value	Volume
35.5¢	35.8¢	35.0¢	$600.1K	1.709M

Buyers (Bids)

No.	Vol.	Price($)
19	1008751	35.0¢

Sellers (Offers)

Price($)	Vol.	No.
35.5¢	200498	11

View Market Depth

No.	Vol.	Price($)
21	1018080	0.350
11	329278	0.345
19	266791	0.340
14	275474	0.335
16	465547	0.330

Price($)	Vol.	No.
0.355	174423	10
0.360	385189	14
0.365	632014	17
0.370	429536	13
0.375	493779	11

Last trade - 15.16pm 29/08/2024 (20 minute delay)

BOT (ASX) Chart